Strategic Advisory Group of Experts
Strategic Advisory Group of Experts (also known as SAGE) is a group of professionals who provide guidance and advice on the development and implementation of vaccination strategies. SAGE is primarily associated with the World Health Organization (WHO), where it serves as the principal advisory group on vaccines and immunization.
History[edit]
The Strategic Advisory Group of Experts was established by the World Health Organization in 1999. Its creation was in response to the need for a global body that could provide expert advice on immunization matters, including the development and implementation of vaccination strategies.
Role and Function[edit]
The primary role of SAGE is to provide guidance to the World Health Organization on overall global policies and strategies, ranging from vaccines and technology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but with all vaccine-preventable diseases.
Membership[edit]
SAGE is composed of 15 experts from around the world, serving in a personal capacity and not as representatives of their respective governments or organizations. The members are chosen for their expertise in clinical medicine, epidemiology, immunology, pediatrics, internal medicine, infectious diseases, public health, and the social sciences related to immunization.
Meetings[edit]
SAGE typically meets twice a year, with additional meetings convened as needed. The meetings are held at the World Health Organization's headquarters in Geneva, Switzerland. The discussions and recommendations of SAGE meetings are published in the WHO Weekly Epidemiological Record.
Impact[edit]
The recommendations of SAGE have a significant impact on global health policies. They guide the work of the World Health Organization and influence the immunization policies of individual countries. SAGE's advice has been instrumental in the global effort to eradicate polio, among other achievements.
See Also[edit]

This World Health Organization related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian